ALB and chronic kidney disease: A significantly higher concentration of serum albumin (5.50, IQR 3.20–5.60 vs 0.80, IQR 0.80–0.80; P ═ 0.018) was seen in the group treated with rosuvastatin MTD compared to the CKD control group.